1466. Antiretroviral (ART) Virologic Suppression (VS) and Patient Reported Outcomes (PROs) at 6 Months in the Clinical Opportunities and Management to Exploit Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) an Asynchronous Connection Key (COMEBACK) Study

BACKGROUND: Effectively interrupting the source of transmission is a critical step in ending the HIV epidemic. COMEBACK (NCT04519970) is a 48-week single-center study in Chicago implemented in September 2020, with its main objectives to reengage lost-to-care patients and rapidly reinitiate ART to pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Roden, Lindsey, Huhn, Gregory, DeMarco, Camille E, Keckler, Kody, Valadez, Patricia Cortes, Burke, Kerianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752682/
http://dx.doi.org/10.1093/ofid/ofac492.1293

Ejemplares similares

Ejemplares similares